Healthcare Triangle signs LOI to buy 51% stake in CosmoInnovations for US $23.5 million

• Healthcare Triangle signed a non-binding LOI to buy a 51% stake in Melbourne-based CosmoInnovations.
• Total consideration set at USD 23.5 million, split between cash, equity, and performance-linked milestones over three years.
• Deal would shift Healthcare Triangle toward a product-led model spanning MedTech, BeautyTech, and consumer-health devices.
• CosmoInnovations portfolio includes 27 granted international patents and 61 pending applications, with a projected USD 50 million three-year revenue pipeline.
• CosmoInnovations’ CirQlight LED technology is manufactured by Shenzhen RedV, which completed FDA establishment registration and device listing for fiscal 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607291610PR_NEWS_USPR_____SF15148) on July 29, 2026, and is solely responsible for the information contained therein.